I et yderligere studie blev 21 mandlige patienter inkluderet for at følge GL3- clearance i nyre - og hudvæv ved et alternativt doseringsregime.
In an additional study, 21 male patients were enrolled to follow GL3 clearance in kidney and skin tissues at an alternative dosing regimen.